在对2,4-滴、环酰菌胺和霜脲氰进行第12条最大残留限量审查后，缺乏确证数据。
Lack of confirmatory data following Article 12 MRL reviews for 2,4-d, fenhexamid and iprovalicarb.
出版信息
EFSA J. 2021 Oct 26;19(10):e06910. doi: 10.2903/j.efsa.2021.6910. eCollection 2021 Oct.
The European Commission mandated EFSA to issue a statement concerning confirmatory data that were not submitted by the set deadline by the applicant following Article 12 reviews under Regulation (EC) No 396/2005 for the following substances/commodity combination: 2,4-d on buckwheat and other pseudo-cereals, fenhexamid on kiwis, iprovalicarb on lettuces, escaroles/broad-leaved endives and roman rocket/rucola. EFSA prepared a statement containing a final conclusion on the completeness of the data necessary to support the existing tentative maximum residue levels (MRLs) and indications to risk managers whether or not the tentative MRLs currently established by Regulation (EC) No 396/2005 could be maintained. The statement was circulated to Member States for consultation via a written procedure before finalisation.
欧盟委员会授权欧洲食品安全局就以下物质/商品组合，根据（欧盟）第396/2005号法规第12条审查后，申请人未在规定期限内提交的确认数据发表声明：荞麦和其他假谷物上的2,4-滴、猕猴桃上的粉唑醇、生菜、菊苣/宽叶苣荬菜和芝麻菜上的霜霉威。欧洲食品安全局编写了一份声明，其中包含关于支持现有暂定最大残留限量（MRLs）所需数据完整性的最终结论，以及向风险管理者表明根据（欧盟）第396/2005号法规目前确定的暂定MRLs是否可以维持。在定稿前，该声明通过书面程序分发给成员国征求意见。
Zotero 插件